Xie X et al.Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma.Oncogene N/A:N/A (2013).
Herfs M et al.A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer.Proc Natl Acad Sci U S A 109:10516-21 (2012).
Phaeton R et al.The influence of proteasome inhibitor MG132, external radiation, and unlabeled antibody on the tumor uptake and biodistribution of (188)Re-labeled anti-E6 C1P5 antibody in cervical cancer in mice.Cancer 116:1067-1074 (2010).
Lawson JS et al.Koilocytes indicate a role for human papilloma virus in breast cancer.Br J Cancer 101:1351-6 (2009).
Lea JS et al.Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.Reprod Sci 14:20-8 (2007).
Zhang Y et al.BRCA1 interaction with human papillomavirus oncoproteins.J Biol Chem 280:33165-77 (2005).
Sirianni N et al.Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.Clin Cancer Res 10:6929-37 (2004).
Abdulkarim B et al.Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.Oncogene 21:2334-46 (2002).
Kobayashi A et al.Lymphoid follicles are generated in high-grade cervical dysplasia and have differing characteristics depending on HIV status.Am J Pathol 160:151-64 (2002).
Banks L et al.Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas.J Gen Virol 68 ( Pt 5):1351-9 (1987).